These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 25083077)
1. Translational approaches: from fatty liver to non-alcoholic steatohepatitis. Rosso N; Chavez-Tapia NC; Tiribelli C; Bellentani S World J Gastroenterol; 2014 Jul; 20(27):9038-49. PubMed ID: 25083077 [TBL] [Abstract][Full Text] [Related]
2. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
3. Iron overload in nonalcoholic steatohepatitis. Fujita N; Takei Y Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026 [TBL] [Abstract][Full Text] [Related]
5. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. Berardo C; Di Pasqua LG; Cagna M; Richelmi P; Vairetti M; Ferrigno A Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348908 [TBL] [Abstract][Full Text] [Related]
7. The Natural Course of Non-Alcoholic Fatty Liver Disease. Calzadilla Bertot L; Adams LA Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213358 [TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237 [TBL] [Abstract][Full Text] [Related]
9. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892 [TBL] [Abstract][Full Text] [Related]
10. Role of liver biopsy in nonalcoholic fatty liver disease. Nalbantoglu IL; Brunt EM World J Gastroenterol; 2014 Jul; 20(27):9026-37. PubMed ID: 25083076 [TBL] [Abstract][Full Text] [Related]
11. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors. Liebig M; Hassanzada A; Kämmerling M; Genz B; Vollmar B; Abshagen K Exp Biol Med (Maywood); 2018 Jan; 243(1):1-12. PubMed ID: 29065724 [TBL] [Abstract][Full Text] [Related]
12. [Research advances in the pathogenesis of non-alcoholic fatty liver disease-associated liver cancer]. Huang W; Zhang XX Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):157-160. PubMed ID: 28297806 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis and cytokines in non-alcoholic steatohepatitis. Syn WK; Choi SS; Diehl AM Clin Liver Dis; 2009 Nov; 13(4):565-80. PubMed ID: 19818305 [TBL] [Abstract][Full Text] [Related]
14. Apoptosis and non-alcoholic fatty liver diseases. Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. Charrez B; Qiao L; Hebbard L World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137 [TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research. Gottlieb A; Mosthael W; Sowa JP; Canbay A Digestion; 2019; 100(2):79-85. PubMed ID: 30537758 [TBL] [Abstract][Full Text] [Related]
18. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease. Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526 [TBL] [Abstract][Full Text] [Related]
19. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280 [TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. Pierantonelli I; Svegliati-Baroni G Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]